May 19, 2022
Drs Thomas Hutson and Scott Tykodi explain when to consider a debulking surgery for patients with renal cell carcinoma.
May 12, 2022
A look at how to best sequence therapies for renal cell carcinoma from the front-line setting on.
May 12, 2022
Thought leaders explain how they dose IO/TKI treatment regimens to better manage side effects in patients with renal cell carcinoma.
May 09, 2022
Dr Scott Tykodi provides advice for community oncologists managing patients with renal cell carcinoma.
March 31, 2022
Thomas Hutson, DO, PharmD, and Scott Tykodi, MD, PhD, discuss their takeaways from the CLEAR trial and how risk category stratification affected the study.
March 31, 2022
Oncologists debate whether TKI monotherapy has a place in renal cell carcinoma treatment after the CLEAR trial.